Clinical Research Directory
Browse clinical research sites, groups, and studies.
Denys-Drash Syndrome and Risk of Post-transplant Lymphoproliferative Disorder
Sponsor: Assistance Publique - Hôpitaux de Paris
Summary
Denys-Drash syndrome is a rare genetic disorder of childhood characterized by nephrotic syndrome, nephroblastomas, and genital developmental abnormalities. These children present with rapidly progressive renal failure, leading to kidney transplantation at a median age of 3.6 years. In a study of the French cohort of patients with Denys-Drash syndrome, a high risk of lymphoproliferative syndrome was observed (20%). This frequency is significantly higher than in the general transplant population (4%). The aim of the study is to evaluate the risk of post-transplant lymphoproliferative disorder following kidney transplantation in patients with Denys-Drash syndrome compared to patients with kidney transplant patients without Denys-Drash syndrome.
Official title: Post-transplant Lymphoproliferative Disorder Following Kidney Transplantation in Denys-Drash Syndrome: a Case-control Study
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
108
Start Date
2026-06
Completion Date
2027-06
Last Updated
2026-05-26
Healthy Volunteers
No
Conditions
Interventions
Collection of data from the patient's medical file
Collection of data from the patient's medical file. The data will be collected until 2024.
Locations (7)
Hôpital Femme Mère Enfant, Hospices Civils de Lyon
Bron, France
CHU de Lille
Lille, France
CHU Montpellier
Montpellier, France
CHU de Nancy - Hôpitaux de Brabois
Nancy, France
Hôpital enfants et adolescents, CHU Nantes
Nantes, France
Hôpital Necker-Enfants Malades
Paris, France
Hôpital Robert Debré
Paris, France